scholarly journals SHR ‐A1403, a novel c‐mesenchymal‐epithelial transition factor (c‐Met) antibody‐drug conjugate, overcomes AZD 9291 resistance in non‐small cell lung cancer cells overexpressing c‐Met

2019 ◽  
Vol 110 (11) ◽  
pp. 3584-3594 ◽  
Author(s):  
Mengya Tong ◽  
Mingzhao Gao ◽  
Yongping Xu ◽  
Li Fu ◽  
Yun Li ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Small Cell ◽  
Small Cell Lung ◽  
Antibody Drug Conjugate ◽  
Mesenchymal Epithelial Transition Factor ◽  
Factor C ◽  
Mesenchymal Epithelial Transition ◽  
Antibody Drug

scholarly journals Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models

mAbs ◽  
2014 ◽  
Vol 6 (2) ◽  
pp. 556-566 ◽  
Author(s):  
Kathleen R Whiteman ◽  
Holly A Johnson ◽  
Michele F Mayo ◽  
Charlene A Audette ◽  
Christina N Carrigan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Antitumor Activity ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Antibody Drug Conjugate ◽  
Xenograft Models ◽  
Antibody Drug ◽  
Human Xenograft Models
Sign in / Sign up

Export Citation Format

Share Document